Our vision

To find a cure for pemphigus and pemphigoid.

Find a doctor

Looking for a doctor who knows how to treat pemphigus or pemphigoid? Find qualified medical and dental professionals in your area. Search our map and filter by specialty.

Find a doctor

Ask a coach

The IPPF’s Peer Health Coaches (PHC) are pemphigus and pemphigoid patients who help more than 1,200 patients and caregivers each year. These specially trained PHCs reduce patient anxiety and uncertainty while providing unbiased disease and treatment knowledge. You can find our PHCs engaging the community through social media, emails, phone calls, and in-person support. The goal of our PHC program is to ensure we help every person who needs assistance in the shortest amount of time possible.

Ask a coach

Clinical Trials and Research

Advocacy and Awareness

12,474
dental professionals reached through exhibits
8,727
students and faculty reached through patient educator program
50
congressional offices visited so far in 2020, advocating on patients’ behalf
8
advocacy support letter sign-ons that will help provide better access to healthcare for our community

Advocacy

The IPPF develops relationships with congressional representatives and other support organizations in order to advocate for favorable state and federal legislation, research funding, and policies or regulations that benefit our community at large.

Learn more about advocacy

Awareness

Our Awareness Program seeks to accelerate diagnosis times by conducting outreach to the dental and medical communities. We focus on the importance of obtaining a correct biopsy for undiagnosed patients, which is the first step toward improving patient quality of life.

Biopsies Save Lives

Tell us your story!

Upcoming Events

Patient Education Webinar Image
Monday, October 26, 2020 12:00pm (PDT)
Patient Education Webinar
Topic: Peer Support with the IPPF Peer Health Coaches

The IPPF offers Patient Education Series Webinars featuring leading pemphigus and pemphigoid physicians and scientists. These free webinars are…

South Florida Virtual Support Group Image
Sunday, November 8, 2020 2:00pm (PST)
South Florida Virtual Support Group
Topic: November

This is a virtual meeting and Zoom information will be sent upon registration.

2021 International Scientific Symposium Image
Sunday, September 19, 2021 12:00am (PDT)
2021 International Scientific Symposium
Topic: Pemphigus and Pemphigoid Lost in Translation: From Mechanisms to Therapy

IPPF Scientific Meeting and Satellite Symposium to the 50th Annual Meeting of the European Society for Dermatological Research (ESDR)…

PemPress

Wednesday, October 21, 2020

Inspiring Hope: Ellen’s Story
Posted by Anna Lane

Thanks to modern medicine, great physicians, and the IPPF, I’ve learned to live confidently and successfully with a rare…

Read more

Friday, October 16, 2020

Inspiring Hope: Noel’s Story
Posted by Anna Lane

The articles on the IPPF website became my daily religion. I started reading them routinely and sharing them with…

Read more

Tuesday, September 22, 2020

The IPPF Welcomes a New Executive Director
Posted by Marc Yale

“I am delighted to join the Foundation. It is clear that the team of staff, Board of Directors, and…

Read more

Wednesday, September 9, 2020

Rituximab to be Included in Taiwan’s National Health Insurance (NHI) Program to Treat Pemphigus Vulgaris
Posted by admippf

Several new drugs used to treat different types of cancer are to be included in the national health insurance…

Read more

Friday, June 26, 2020

Information for Pemphigus and Pemphigoid Patients Related to COVID-19
Posted by admippf

This page was last updated on September 17, 2020. As news of coronavirus disease (COVID-19) changes hour by hour,…

Read more

Thursday, May 7, 2020

Cabaletta Bio Receives FDA Fast Track Designation for DSG3- CAART for the Treatment of Mucosal PV
Posted by admippf

The U.S. FDA has granted Fast Track Designation for DSG3-CAART, Cabaletta Bio’s lead product candidate for treatment of mucosal…

Read more

Tuesday, February 25, 2020

Advocacy in Action
Posted by Rebecca Strong

You may be aware of the IPPF’s advocacy efforts. Now, we need you to advocate, too. Your story is…

Read more

Monday, February 17, 2020

Cabaletta Bio Announces FDA Orphan Drug Designation for DSG3- CAART for the Treatment of Pemphigus Vulgaris
Posted by admippf

Cabaletta Bio, Inc., a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients…

Read more

Sunday, January 5, 2020

Positive Proof-of-Concept Data for Efgartigimod in Pemphigus Vulgaris
Posted by admippf

23 patients were evaluated for efficacy in an adaptive Phase 2 trial aiming to establish optimal treatment regimen argenx,…

Read more

Tuesday, October 15, 2019

Phase III PEMPHIX Study Shows Genentech’s Rituxan (Rituximab) Superior to Mycophenolate Mofetil in Patients With Pemphigus Vulgaris
Posted by admippf

Genentech, a member of the Roche Group, announced data this week from the Phase III PEMPHIX study evaluating the…

Read more

Support our critical patient services, research, advocacy, and awareness efforts today

Ways to Give